Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 73, Issue 7, 2005, Pages 487-497

  Gelineau Van Waes, Janee ^a,c   Starr, Lois ^a   Maddox, Joyce ^a   Aleman, Francisco ^a   Voss, Kenneth A ^b   Wilberding, Justin ^a   Riley, Ronald T ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Folate; Fumonisin; Ganglioside GM1; Lipid raft; Neural tube defects; Sphingolipids

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; FUMONISIN B1; GANGLIOSIDE; GANGLIOSIDE GM1; GLYCOSPHINGOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; MYCOTOXIN; PROTEIN FOLBP1; SPHINGOLIPID; SPHINGOSINE ACYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORN; DIET SUPPLEMENTATION; EMBRYO; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; FEMALE; FETUS; FETUS MALFORMATION; FUSARIUM; FUSARIUM VERTICILLIODES; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID METABOLISM; LIPID RAFT; LIPOGENESIS; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOGENICITY;

ANIMALS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; FUMONISINS; G(M1) GANGLIOSIDE; IMMUNOHISTOCHEMISTRY; MALE; MATERNAL-FETAL EXCHANGE; MICE; MYCOTOXINS; NEURAL TUBE DEFECTS; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, CELL SURFACE; SPHINGOLIPIDS; SPHINGOSINE; TERATOGENS;

ANIMALIA; FUNGI; FUSARIUM; GIBBERELLA MONILIFORMIS; ZEA MAYS;

EID: 22944452718     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20148     Document Type: Article

References (65)

1. Betz FS, Hammond BG, Fuchs RL. 2000. Safety and advantages of Bacillus thuringiensis-protected plants to control insect pests. Regul Toxicol Pharmacol 32:156-173.
2. Bolger MC, Coker RD, Dinovi M, Gaylor D, et al. 2001. Fumonisins. In: Safety evaluation of certain mycotoxins in food. Food and Agriculture Organization of the United Nations, World Health Organization. Geneva: Food Additives, Series 47, Paper 74. pp. 103-279.
3. Brown DA, London E. 1998. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136.
4. Cacic M. 1995. Gangliosides of anencephalic and fetal brain-immunostaining on thin-layer chromatograms. Neuroreport 6:389-393.
5. Campbell LR, Dayton DH, Sohal GS. 1986. Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 34:171-187.
6. Collins TF, Shackelford ME, Sprando RL, et al. 1998. Effects of fumonisin B1 in pregnant rats. Food Chem Toxicol 36:397-408.
7. Czeizel AE, Dudas J. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
8. da Costa M, Sequeira JM, Rothenberg SP, Weedon J. 2003. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res Part A Clin Mol Teratol 67:837-847.
9. Dombrink-Kurtzman MA, Dvorak TJ, Barron ME, Rooney LW. 2000. Effect of nixtamalization (alkaline cooking) on fumonisin-contaminated corn for production of masa and tortillas. J Agric Food Chem 48:5781-5786.
10. Duvick J. 2001. Prospects for reducing fumonisin contamination of maize through genetic modification. Environ Health Perspect 109(Suppl 2): 337-342.
11. Elortza F, Nuhse TS, Foster LJ, et al. 2003. Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins. Mol Cell Proteomics 2:1261-1270.
12. Floss JL, Casteel SW, Johnson GC, et al. 1994. Development toxicity of fumonisin in Syrian hamsters. Mycopathologia 128:33-38.
13. Flynn TJ, Pritchard D, Bradlaw JA, et al. 1996. In vitro embryotoxicity of fumonisin B1 evaluated with cultured postimplantation staged rat embryos. In Vitro Toxicology 9:271-279.
14. Flynn TJ, Stack ME, Troy AL, Chirtel SJ. 1997. Assessment of the embryotoxic potential of the total hydrolysis product of fumonisin B1 using cultured organogenesis-staged rat embryos. Food Chem Toxicol 35: 1135-1141.
15. Foster LJ, De Hoog CL, Mann M. 2003. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100:5813-5818.
16. Gelderblom WC, Jaskiewicz K, Marasas WF, et al. 1988. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 54:1806-1811.
17. Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. 1991. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12:1247-1251.
18. Gross SM, Reddy RV, Rottinghaus GE, et al. 1994. Developmental effects of fumonisin B1-containing Fusarium moniliforme culture extract in CD1 mice. Mycopathologia 128:111-118.
19. Hansen DK, Streck RD, Antony AC. 2003. Antisense modulation of the coding or regulatory sequence of the folate receptor (folate binding protein-1) in mouse embryos leads to neural tube defects. Birth Defects Res Part A Clin Mol Teratol 67:475-487.
20. Harris MJ, Juriloff DM, Biddle FG. 1984. Cortisone cure of the lidgap defect in fetal mice: a dose-response and time-response study. Teratology 29:287-295.
21. Hendricks K. 1999. Fumonisins and neural tube defects in South Texas. Epidemiology 10:198-200.
22. Hoessli DC, Ilangumaran S, Soltermann A, et al. 2000. Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform. Glycoconj J 17:191-197.
23. 3H)-GM1 and its distribution to maternal and fetal tissues of the rat. Life Sci 53:113-119.
24. IARC. 2000. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Lyon: IARC Press, pp. 301-366.
25. Juriloff DM, Harris MJ, Miller JR. 1983. The lidgap defect in mice: update and hypotheses. Can J Genet Cytol 25:246-254.
26. Kromberg JG, Jenkins T. 1982. Common birth defects in South African Blacks. S Afr Med J 62:599-602.
27. LaBorde JB, Terry KK, Howard PC, et al. 1997. Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits. Fundam Appl Toxicol 40:120-128.
28. Marasas WF, Riley RT, Hendricks KA, et al. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134:711-716.
29. Martinez-Larranaga MR, Anadon A, Diaz MJ, et al. 1999. Toxicokinetics and oral bioavailability of fumonisin B1. Vet Hum Toxicol 41:357-362.
30. Melnick M, Marazita ML. 1998. Neural tube defects, methylenetetrahydrofolate reductase mutation, and north/south dietary differences in China. J Craniofac Genet Dev Biol 18:233-235.
31. Meredith FI, Torres OR, Saenz de Tejada S, et al. 1999. Fumonisin B1 and hydrolyzed fumonisin B1 (AP1) in tortillas and nixtamalized corn (Zea mays L.) from two different geographic locations in Guatemala. J Food Prot 62:1218-1222.
32. Merrill AH Jr, Sullards MC, Wang E, et al. 2001. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 109(Suppl 2):283-289.
33. Miotti S, Bagnoli M, Tomassetti A, et al. 2000. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. J Cell Sci 113(Pt 2):349-357.
34. Moore CA, Li S, Li Z, et al. 1997. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 73:113-118.
35. MRC. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338:131-137.
36. Nakano KK. 1973. Anencephaly: a review. Dev Med Child Neurol 15:383-400.
37. Ncayiyana DJ. 1986. Neural tube defects among rural blacks in a Transkei district. A preliminary report and analysis. S Afr Med J 69:618-620.
38. Norred WP, Plattner RD, Dombrink-Kurtzman MA, et al. 1997. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Toxicol Appl Pharmacol 147:63-70.
39. National Toxicology Program. 2001. NTP Technical Report on the toxicology and Carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). TR 496, NIH Publication No. 99-3955, Public Health Service, National Institutes of Health.
40. Palencia E, Torres O, Hagler W, et al. 2003. Total fumonisins are reduced in tortillas using the traditional nixtamalization method of Mayan communities. J Nutr 133:3200-3203.
41. Penner JD, Casteel SW, Pittman L Jr, et al. 1998. Developmental toxicity of purified fumonisin B1 in pregnant Syrian hamsters. J Appl Toxicol 18:197-203.
42. Piedrahita JA, Oetama B, Bennett GD, et al. 1999. Mice lacking the folic acid-binding protein Folbpl are defective in early embryonic development. Nat Genet 23:228-232.
43. Powell DC, Bursian SJ, Bush CR, et al. 1996. Effects of dietary exposure to fumonisins from Fusarium moniliforme culture material (M-1325) on the reproductive performance of female mink. Arch Environ Contam Toxicol 31:286-292.
44. Prelusky DB, Trenholm HL, Savard, ME. 1994. Pharmacokinetic fate of 14C-labelled fumonisin B1 in swine. Nat Toxins 2:73-80.
45. Prelusky DB, Miller JD, Trenholm, HL. 1996. Disposition of 14C-derived residues in tissues of pigs fed radiolabelled fumonisin B1. Food Addit Contam 13:155-162.
46. Reddy RV, Johnson G, Rottinghaus GE, et al. 1996. Developmental effects of fumonisin B1 in mice. Mycopathologia 134:161-166.
47. Riley RT, An NH, Showker JL, et al. 1993. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol Appl Pharmacol 118:105-112.
48. Riley RT, Plattner RD. 2000. Fermentation, partial purification, and use of serine palmitoyltransferase inhibitors from Isaria (= Cordyceps) sinclairii. Methods Enzymol 311:348-361.
49. Riley RT, Wang E, Schroeder JJ, et al. 1996. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins 4:3-15.
50. Rothenberg SP, Da Costa MP, Sequeira JM, et al. 2004. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. Obstet Gynecol Surv 59:410-411.
51. Sadler TW, Merrill AH, Stevens VL, et al. 2002. Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 66:169-176.
52. Saitsu H, Ishibashi M, Nakano H, Shiota K. 2003. Spatial and temporal expression of folate-binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice. Dev Dyn 226:112-117.
53. Shaw GM, Schaffer D, Velie EM, et al. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
54. Shephard GS, Thiel PG, Sydenham EW. 1992. Initial studies on the toxicokinetics of fumonisin B1 in rats. Food Chem Toxicol 30:277-279.
55. Silani V, Bonifati C, Buscaglia M, et al. 1993. Ganglioside GM1 expression during human spinal cord and neural crest development. Neuroreport 4:767-770.
56. Stevens VL, Tang J. 1997. Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem 272:18020-18025.
57. van der Westhuizen L, Shephard GS, van Schalkwyk DJ. 2001. The effect of a single gavage dose of fumonisin B(1) on the sphinganine and sphingosine levels in vervet monkeys. Toxicon 39:273-281.
58. Voss KA, Bacon CW, Norred WP, et al. 1996. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats. Nat Toxins 4:24-33.
59. Voss KA, Riley RT, Norred WP, et al. 2001. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect 109(Suppl 2):259-266.
60. Wang E, Norred WP, Bacon CW, et al. 1991. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 266:14486-14490.
61. Watanabe R, Funato K, Venkataraman K, et al. 2002. Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol- anchored proteins in yeast. J Biol Chem 277:49538-49544.
62. Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269:1257-1261.
63. WHO. 2000. United Nations Environmental Programme, the International Labour Organization and the World Health Organization International Programme on Chemical Safety. Geneva: WHO. 153 p.
64. Xiao KZ, Zhang ZY, Su YM, et al. 1990. Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monitoring Program. Int J Epidemiol 19:978-982.
65. Yu RK, Bieberich E, Xia T, Zeng G. 2004. Regulation of ganglioside biosynthesis in the nervous system. J Lipid Res 45:783-793.